- $243.85m
- $300.32m
- $711.78m
- 54
- 77
- 93
- 88
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 708 | 710 | 601 | 748 | 712 |
Cost of Revenue | |||||
Gross Profit | 64 | 84.7 | 41 | 50.7 | 61.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 706 | 683 | 611 | 756 | 718 |
Operating Profit | 2.19 | 26.6 | -9.32 | -8.03 | -6.63 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.49 | 22.2 | -14.1 | -12.2 | -17.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.36 | 20.2 | -14.6 | -12.6 | -17.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -5.36 | 20.2 | -14.6 | -12.6 | -17.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.36 | 20.2 | -14.6 | -12.6 | -17.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.102 | 0.501 | -0.715 | -0.504 | -0.584 |